Therapeutic Potential and Sustainable Bioprocessing of Enterocin CC2: A Probiotic-Derived Antimicrobial Targeting Streptococcus mutans in Oral Health
Probiotics and Antimicrobial Proteins · 2025
DOI: 10.1007/s12602-025-10773-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Probiotics and Antimicrobial Proteins, 2025. Verfasst von Zhang Jin Ng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bioprocess Technology, School of Industrial Technology, Universiti Sains Malaysia, 11800, Gelugor, Pulau Pinang, Malaysia. Hauptthemen laut MEDLINE: Streptococcus mutans, Bacteriocins, Probiotics, Enterococcus faecium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Universiti Sains Malaysia.
Themen: Mundpflege
Abstract (Originalsprache)
The growing threat of antimicrobial resistance in oral pathogens necessitates safe and sustainable alternatives to conventional therapies. Enterocin CC2, a novel bacteriocin from Enterococcus faecium CC2, was purified using an optimized polyethylene glycol (PEG)-citrate aqueous two-phase system (ATPS). The process achieved a purification factor of 4.73 and recovery yield of 73.33%, which improved to 5.13 and 84.61% with the addition of 4% NaCl. SDS-PAGE revealed a molecular size of ~ 5.5-6 kDa, and identity confirmation was obtained via HPLC and LC-MS. Enterocin CC2 displayed potent antimicrobial activity against Streptococcus mutans with MIC and MBC values of 0.50 and 1.00 mg/mL, respectively, and demonstrated faster bactericidal action than 0.2% chlorhexidine. ISO 10993-5 cytotoxicity testing confirmed its safety on 3T3-L1 cells at concentrations ≤ 1 mg/mL. These findings highlight enterocin CC2 as a promising candidate for oral health applications and establish PEG-citrate ATPS as a scalable, eco-friendly platform for bacteriocin purification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioprocess Technology, School of Industrial Technology, Universiti Sains Malaysia, 11800, Gelugor, Pulau Pinang, Malaysia.
- Analytical Biochemistry Research Centre (ABrC), University Innovation Incubator Building, Universiti Sains Malaysia, Sains@USM Campus, 11900, Bayan Lepas , Penang, Malaysia.
- Laboratory Vaccines and Biomolecules, Institute of Bioscience, Universiti Putra Malaysia, UPM Serdang, 43400, Serdang, Selangor, Malaysia.
- Biorefinery and Bioprocessing Engineering Laboratory, Department of Chemical Engineering and Materials Science, Yuan Ze University, Chungli, Taoyuan, 320, Taiwan.
- Department of Chemical Engineering and Materials Science, Yuan Ze University, Chungli, Taoyuan, 320, Taiwan.
- Smart Bioresource Recovery and Formulation Laboratory, Department of Chemical Engineering and Materials Science, Yuan Ze University, Chungli, Taoyuan, 320, Taiwan.
Förderung
- Universiti Sains Malaysia
Zitieren
APA
Ng, Z. J., Gan, C. Y., Zarin, M. A., Lee, C. K., Lan, J. C., Ng, H. S., & Tan, J. S. (2025). Therapeutic Potential and Sustainable Bioprocessing of Enterocin CC2: A Probiotic-Derived Antimicrobial Targeting Streptococcus mutans in Oral Health. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-025-10773-2
Vancouver
Ng ZJ, Gan CY, Zarin MA, Lee CK, Lan JC, Ng HS, et al. Therapeutic Potential and Sustainable Bioprocessing of Enterocin CC2: A Probiotic-Derived Antimicrobial Targeting Streptococcus mutans in Oral Health. Probiotics and Antimicrobial Proteins. 2025. doi:10.1007/s12602-025-10773-2
BibTeX
@article{Ng2025,
author = {Ng, Zhang Jin and Gan, Chee-Yuen and Zarin, Mazni Abu and Lee, Chee Keong and Lan, John Chi-Wei and Ng, Hui Suan and Tan, Joo Shun},
title = {Therapeutic Potential and Sustainable Bioprocessing of Enterocin CC2: A Probiotic-Derived Antimicrobial Targeting Streptococcus mutans in Oral Health},
journal = {Probiotics and Antimicrobial Proteins},
year = {2025},
doi = {10.1007/s12602-025-10773-2}
}
EUVIMED